BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 32310190)

  • 1. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19.
    Alzoughool F; Alanagreh L
    Int J Risk Saf Med; 2020; 31(2):47-51. PubMed ID: 32310190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio Interview: Capitalizing on Immune Responses to Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent plasma - Is it useful for treating SARS Co-V2 infection?
    Ranganathan S; Iyer RN
    Indian J Med Microbiol; 2020; 38(3 & 4):252-260. PubMed ID: 33154232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 9. The convalescent sera option for containing COVID-19.
    Casadevall A; Pirofski LA
    J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
    [No Abstract]   [Full Text] [Related]  

  • 10. Deployment of convalescent plasma for the prevention and treatment of COVID-19.
    Bloch EM; Shoham S; Casadevall A; Sachais BS; Shaz B; Winters JL; van Buskirk C; Grossman BJ; Joyner M; Henderson JP; Pekosz A; Lau B; Wesolowski A; Katz L; Shan H; Auwaerter PG; Thomas D; Sullivan DJ; Paneth N; Gehrie E; Spitalnik S; Hod EA; Pollack L; Nicholson WT; Pirofski LA; Bailey JA; Tobian AA
    J Clin Invest; 2020 Jun; 130(6):2757-2765. PubMed ID: 32254064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma.
    Lindholm PF; Ramsey G; Kwaan HC
    Semin Thromb Hemost; 2020 Oct; 46(7):796-803. PubMed ID: 32526774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for emerging viruses: Convalescent plasma and COVID-19.
    Brown BL; McCullough J
    Transfus Apher Sci; 2020 Jun; 59(3):102790. PubMed ID: 32345485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing Clinical Trials for the Management of the COVID-19 Pandemic.
    Lythgoe MP; Middleton P
    Trends Pharmacol Sci; 2020 Jun; 41(6):363-382. PubMed ID: 32291112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: Main therapeutic options.
    Hachfi W; Ben Lasfar N
    Tunis Med; 2020 Apr; 98(4):299-303. PubMed ID: 32395792
    [No Abstract]   [Full Text] [Related]  

  • 16. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization.
    Klasse PJ; Moore JP
    Elife; 2020 Jun; 9():. PubMed ID: 32573433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2.
    Zhou G; Zhao Q
    Int J Biol Sci; 2020; 16(10):1718-1723. PubMed ID: 32226289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase.
    Halstead SB; Akkina R
    Front Immunol; 2020; 11():1196. PubMed ID: 32574267
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.